Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women.

Vague P, Juhan-Vague I, Chabert V, Alessi MC, Atlan C.

Metabolism. 1989 Sep;38(9):913-5.

PMID:
2505018
2.

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, Pagano C, Scaraggi FA, Di Lorenzo L, Giorgino R.

Metabolism. 1999 Aug;48(8):960-4.

PMID:
10459558
3.

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.

Metabolism. 1997 Nov;46(11):1287-93.

PMID:
9361687
4.

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U.

Metabolism. 1990 Oct;39(10):1044-8.

PMID:
2215252
6.

Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.

Polac I, Stachowiak G, Jedrzejczyk S, Stetkiewics T, Sobieszczanska S, Pertynski T.

Gynecol Endocrinol. 2003 Apr;17(2):151-7.

PMID:
12744226
7.

Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C.

Diabete Metab. 1987 Jul;13(3 Pt 2):331-6.

PMID:
3115843
8.

Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).

Atiomo WU, Fox R, Condon JE, Shaw S, Friend J, Prentice AG, Wilkin TJ.

Clin Endocrinol (Oxf). 2000 Apr;52(4):487-92.

PMID:
10762292
9.

Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.

Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Hamsten A, Arner P.

Diabetologia. 1998 Jan;41(1):65-71.

PMID:
9498632
10.

The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.

Sudi KM, Gallistl S, Tröbinger M, Payerl D, Weinhandl G, Muntean W, Aigner R, Borkenstein MH.

J Pediatr Endocrinol Metab. 2001 Jan;14(1):85-94.

PMID:
11220710
11.

Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.

Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE, McCullough P.

Metabolism. 2001 Jul;50(7):856-61.

PMID:
11436194
12.

Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premenopausal women with central obesity.

De Pergola G, De Mitrio V, Perricci A, Cignarelli M, Garruti G, Lomuscio S, Ferri G, Schiraldi O, Giorgino R.

Metabolism. 1992 Feb;41(2):131-4.

PMID:
1736034
14.

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.

You T, Yang R, Lyles MF, Gong D, Nicklas BJ.

Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E741-7.

16.

Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution.

Landin K, Krotkiewski M, Smith U.

Metabolism. 1989 Jun;38(6):572-6.

PMID:
2657328
17.

Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.

De Pergola G, De Mitrio V, Giorgino F, Sciaraffia M, Minenna A, Di Bari L, Pannacciulli N, Giorgino R.

Int J Obes Relat Metab Disord. 1997 Jul;21(7):527-535.

PMID:
9226481
18.

Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.

Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.

Obes Res. 2002 Aug;10(8):717-25.

19.

Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.

van Harmelen V, Wahrenberg H, Eriksson P, Arner P.

Thromb Haemost. 2000 Feb;83(2):304-8.

PMID:
10739390
20.

Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution.

Avellone G, Di Garbo V, Cordova R, Raneli G, De Simone R, Bompiani G.

Thromb Res. 1994 Aug 1;75(3):223-31.

PMID:
7992233
Items per page

Supplemental Content

Support Center